Company Filing History:
2 out of 3,923 
1 out of 149 
1 out of 340 Years Active: 1998-2022
Title: Michael Broeker: Innovator in Pharmaceutical Applications
Introduction
Michael Broeker is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the production of squalene and vaccine development. With a total of 4 patents, his work has implications for both medical and industrial applications.
Latest Patents
One of Broeker's latest patents focuses on the production of squalene from hyper-producing yeasts. This method involves preparing purified yeast, where the squalene source is a yeast that hyper-produces squalene. The squalene produced is particularly useful for pharmaceutical purposes, such as preparing an oil-in-water emulsion that serves as an immunological adjuvant. Another significant patent involves a live attenuated influenza vaccine that contains a H1 subtype influenza A strain. This vaccine's hemagglutinin is more closely related to SEQ ID NO: 1 than to SEQ ID NO: 3, showcasing his innovative approach to vaccine development.
Career Highlights
Throughout his career, Michael Broeker has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Dade Behring Marburg GmbH. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical technology.
Collaborations
Michael has collaborated with notable colleagues such as Hans-Peter Harthus and Klaus Stöhr. These partnerships have further enhanced his research and development efforts, leading to impactful innovations in the field.
Conclusion
Michael Broeker's contributions to pharmaceutical innovations, particularly in squalene production and vaccine development, highlight his role as a significant inventor in the industry. His work continues to influence advancements in medical applications, showcasing the importance of innovation in healthcare.